S22-388 Insulin receptor antagonist Researchers at Stanford have developed a potent, insulin-based, insulin receptor antagonist that could be used as a hyperinsulinism therapeutic. Danny Hung-Chieh Chou Claire Park Nai-Pin Lin
S20-273 Expansion of Human iPSC-derived Cardiomyocytes In Vitro Through Small Molecule Inhibition of Cell-Cell Contact Stanford inventors have identified a treatment regimen that allows expansion of cardiomyocytes (CMs) derived from human induced pluripotent stem cells in vitro. Sean Wu Soah Lee